Thus, unsurprisingly, the knockdown of TMPO-AS1 suppressed growth and increased apoptosis in thyroid cancer (76), glioma progression (77), and cell proliferation and motility in pancreatic carcinoma (72). This evidence concerns the gene TMPO and central nervous system cancer.